The value of quantitative EEG in differential diagnosis of Alzheimer's disease and subcortical vascular dementia

2009 ◽  
Vol 283 (1-2) ◽  
pp. 265
Author(s):  
M. Gawel ◽  
E. Zalewska ◽  
E. Szmidt-Salkowska ◽  
J. Kowalski
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Differential Diagnosis ◽  
Vascular Dementia ◽  
Quantitative Eeg ◽  
Subcortical Vascular Dementia

IC-P-146: Corpus Callosum Atrophy in Alzheimer's Disease and Subcortical Vascular Dementia : The LADIS Study

2010 ◽  
Vol 6 ◽  
pp. S57-S58
Author(s):  
Kristian S. Jensen ◽  
Ellen Garde ◽  
Arnold Skimminge ◽  
Frederik Barkhof ◽  
Philip Scheltens ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Corpus Callosum ◽  
Vascular Dementia ◽  
Subcortical Vascular Dementia

Survival in Subcortical Vascular Dementia: Predictors and Comparison to Probable Alzheimer's Disease in a Tertiary Memory Clinic Population

2015 ◽  
Vol 40 (3-4) ◽  
pp. 210-221 ◽  
Author(s):  
Jong Hun Kim ◽  
Seok Min Go ◽  
Sang Won Seo ◽  
Suk Hui Kim ◽  
Juhee Chin ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Family History ◽  
Vascular Dementia ◽  
Proportional Hazards Model ◽  
Late Onset ◽  
Cox Proportional Hazards ◽  
Cox Proportional Hazards Model ◽  
Subcortical Vascular Dementia ◽  
History Of

Background: Subcortical vascular dementia (SVaD) is one of the most common dementias, after Alzheimer's disease (AD) dementia. Few survival analyses in SVaD patients have been reported. Methods: The dates and causes of death of 146 SVaD and 725 AD patients were included. We used the Cox proportional hazards model to compare survival between SVaD and AD patients and to explore possible factors related to survival of SVaD patients. Results: The median survival time after the onset of SVaD (109 months) was shorter than that recorded for AD (152 months). The most common cause of death in SVaD was stroke (47.1%). Factors associated with shorter survival in SVaD were late onset, male sex, worse baseline cognition, absence of hypertension and a family history of stroke. Conclusions: Stroke prevention may be important in SVaD treatment because 47.1% of SVaD patients died of stroke. A family history of stroke and absence of hypertension were associated with a shorter survival in SVaD, suggesting the existence of genetic or unknown risk factors.

Can measurement of CSF α 1-Antichymotrypsin be a useful tool for differential diagnosis of vascular dementia and Alzheimer's disease?

1992 ◽  
Vol 2 (4) ◽  
pp. 234-236 ◽  
Author(s):  
Yukito Shinohara ◽  
Katsunori Akiyama ◽  
Hiroshi Tachikawa ◽  
Masahiro Yamamoto ◽  
Michio Tsuda ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Differential Diagnosis ◽  
Vascular Dementia
Sign in / Sign up

Export Citation Format

Share Document